Skip to main content
SpringerLink
Log in

Beta-blockers do not protect against cardiac toxicity of hyperkalemia

Response to the article by Legrand et al. ‘Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications’ [1]

  • Letter to the Editors
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. GREAT (Global Research on Acute Conditions Team) Network and INI-CRCT (Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists) network, Legrand M, Ludes P-O et al (2017) Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications. Clin Res Cardiol. https://doi.org/10.1007/s00392-017-1173-3

    Article  Google Scholar 

  2. Chilton L (2005) K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. AJP Heart Circ Physiol 288:H2931–H2939. https://doi.org/10.1152/ajpheart.01220.2004

    Article  CAS  Google Scholar 

  3. Hodgkin AL, Horowicz P (1959) The influence of potassium and chloride ions on the membrane potential of single muscle fibres. J Physiol 148:127–160

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Biel M (2002) Cardiac HCN channels structure, function, and modulation. Trends Cardiovasc Med 12:206–213. https://doi.org/10.1016/S1050-1738(02)00162-7

    Article  PubMed  CAS  Google Scholar 

  5. (2004) Expert consensus document on B-adrenergic receptor blockers the task force on beta-blockers of the European society of cardiology. Eur Heart J 25:1341–1362. https://doi.org/10.1016/j.ehj.2004.06.002

Download references

Author information

Authors and Affiliations

  1. Department of Anaesthesiology and Cardiovascular/Surgical Intensive Care Unit, Groupe Hospitalier Bichat Claude Bernard, HUPNVS, Assistance Publique Hôpitaux de Paris, Paris, France

    Christian de Tymowski, Enora Atchade, Philippe Montravers & Sophie Provenchère

  2. Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, Paris, France

    Christian de Tymowski & Philippe Montravers

  3. INSERM UMR 1152, centre de recherche sur l’inflammation, Paris, France

    Philippe Montravers

  4. Laboratoty INSERM 1149, Faculté de Bichat, 16 rue Henri Hichard, 75018, Paris, France

    Christian de Tymowski

Authors
  1. Christian de Tymowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Enora Atchade
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philippe Montravers
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sophie Provenchère
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian de Tymowski.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Tymowski, C., Atchade, E., Montravers, P. et al. Beta-blockers do not protect against cardiac toxicity of hyperkalemia. Clin Res Cardiol 107, 868–869 (2018). https://doi.org/10.1007/s00392-018-1226-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-018-1226-2

Search

Navigation